Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial.

ABSTRACT:

Importance

Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to surgical aortic valve replacement and is the treatment of choice for patients at high operative risk. The role of TAVI in patients at lower risk is unclear.

Objective

To determine whether TAVI is noninferior to surgery in patients at moderately increased operative risk.

Design, setting, and participants

In this randomized clinical trial conducted at 34 UK centers, 913 patients aged 70 years or older with severe, symptomatic aortic stenosis and moderately increased operative risk due to age or comorbidity were enrolled between April 2014 and April 2018 and followed up through April 2019.

Interventions

TAVI using any valve with a CE mark (indicating conformity of the valve

SUBMITTER: UK TAVI Trial Investigators 

PROVIDER: S-EPMC9115619 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature